• Home
    • Medication Information Library
    • Medication Interactions
    • Medication Identifier
  • Comments
  • Posts
meds watch
CHEST
  • Home
  • Meds-Watch Home
  • Medication Information Library
  • Medication Interactions
  • Medication Identifier
The Medical Letter Online

Human medicines European Public Assessment Report (EPAR): ATryn, antithrombin alfa, Revision: 9, Authorised

admin | May 12, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Tags: alfa, antithrombin, assessment, ATryn, Authorised, EPAR, European, human, medicines, Public, report, Revision

Category: European Medicines Agency

Subscribe

If you enjoyed this article, subscribe to receive more just like it.

Subscribe via RSS Feed

Leave a Reply

Click here to cancel reply.

« Scientific Advisory Committee on Nonprescription Drugs (SAC-NPD) – Draft Agenda
NADOLOLtablet [Teva Pharmaceuticals USA Inc] »

Archives

  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
Poison Help

RSS ASHP – Current Drug Product Shortages

  • Papaverine Injection None May 31, 2013
    Drug: Papaverine Injection, Revision Date: Fri, 31 May 2013 […]
  • Caffeine and Sodium Benzoate Injection None May 31, 2013
    Drug: Caffeine and Sodium Benzoate, Revision Date: Fri, 31 May 2013 […]
  • Nicardipine Hydrochloride Injection Some May 31, 2013
    Drug: Nicardipine, Revision Date: Fri, 31 May 2013 […]
  • Sterile Empty Vials May 31, 2013
    Drug: Sterile Empty Vials, Revision Date: Fri, 31 May 2013 […]

RSS ASHP – Resolved Drug Shortages

  • Pyridostigmine Bromide Injection All May 31, 2013
    Drug: Pyridostigmine Bromide, Revision Date: Fri, 31 May 2013 […]
  • Cefaclor Suspension Some May 15, 2013
    Drug: Cefaclor, Revision Date: Wed, 15 May 2013 […]
  • Foscarnet Injection May 10, 2013
    Drug: Foscarnet, Revision Date: Fri, 10 May 2013 […]
  • Mepivacaine Injection May 9, 2013
    Drug: Mepivacaine, Revision Date: Thu, 09 May 2013 […]

RSS ASHP – Drug Products No Longer Available

  • Ganciclovir Capsules None May 24, 2013
    Drug: Ganciclovir Capsules, Revision Date: Fri, 24 May 2013 […]
  • Japanese Encephalitis Virus Inactivated Vaccine May 22, 2013
    Drug: Japanese Encephalitis Virus Inactivated Vaccine, Revision Date: Wed, 22 May 2013 […]
  • Mesalamine 400 mg Delayed-Release Tablet (Asacol) April 5, 2013
    Drug: Mesalamine, Revision Date: Fri, 05 Apr 2013 […]
  • Sotalol Injection None March 26, 2013
    Drug: Sotalol, Revision Date: Tue, 26 Mar 2013 […]

Categories

  • European Medicines Agency
  • FDA Drug Info Rounds
  • FDA Drug Shortages
  • Health Canada
  • Latest Medication News
  • MedEffect Canada
  • Medications
  • MedWatch Safety Alerts
  • Nature reviews-Drug Discovery
  • Recalls
  • What's New: Drugs

RSS Latest Medication News

  • Anticancer drugs: Blocking RAS effects May 31, 2013 Darren J. Burgess
  • Menelas Pangalos May 31, 2013 AsherMullard
  • LifeTrain: towards a European framework for continuing professional development in biomedical sciences May 31, 2013 Mike Hardman
  • Trial watch: Opioid receptor blocker shows promise in Phase II depression trial May 31, 2013 Charlotte Harrison
  • All-oral HCV therapies near approval May 31, 2013 Man Tsuey Tse
  • Neurodegenerative diseases: Simple amyloids to provide protection in MS? May 31, 2013 Alexandra Flemming
  • Integrin inhibitors go with the gut May 31, 2013 David Holmes
  • Regulatory watch: Enhanced chance of success for protein replacement therapies May 31, 2013 Sarah Crunkhorn
  • Drug spending down May 31, 2013
  • Patent watch May 31, 2013 Charlotte Harrison

Recent Posts

  • Test Your Home for Radon During Lung Cancer Awareness Month
  • News and press releases: European Medicines Agency website unavailable intermittently Saturday 6 October
  • Ameridose Issues Recall of All Products
  • Classic Zi Xiu Tang Bee Pollen Capsules And Ultimate Formula Capsules by Zi Xiu Tang Success: Recall – Undeclared Sibutramine
  • Metabolic disorders: Safe cannabinoid receptor modulators in sight?

Tags

2012 adopted Agency Alert Allergy assessment Authorised Because Class Communication Current Decision Draft Drug Drugs EPAR European Final From Health human Inc. Injection Issues medicines News Notice Possible Potential Press Product Products Public Recall Recalls Releases report Revision Risk Safety Shortages Solution Undeclared updated Voluntary

meds watch

© 2013 meds watch. All rights reserved. Premium WordPress Themes.